AZTA
Azenta·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 5
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
Significant Net Income Growth
EPS Beats Expectation
RSI Oversold
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AZTA
Azenta, Inc.
A global provider of life sciences and advanced specialty chemicals
Semiconductor Products and Equipment
--
02/03/1995
NASDAQ Stock Exchange
3,000
09-30
Common stock
200 Summit Drive 6th Floor, Burlington, Massachusetts 01803
--
Azenta, Inc., is a Delaware corporation established in 1978. The company is a leading global provider of biological and chemical compound sample exploration and management solutions for the life science industry. The company entered the life sciences market in 2011, leveraging the in-house precision automation and cryogenic capabilities they applied in the semiconductor manufacturing market at the time. Since then, the company has expanded its life science offerings through internal investments and a series of acquisitions. The company now supports clients from research and clinical development to commercialization with sample management, automated storage and genomic services expertise to help clients bring influential therapies to market faster. The company understands the importance of sample integrity and supports customers with a broad portfolio of products and services at every stage of the sample life cycle, including procurement and procurement, automated storage systems, genomic services and bulk sample consumables, informatics and data software, and sample repository solutions.
Company Financials
EPS
AZTA has released its 2026 Q1 earnings. EPS was reported at 0.09, versus the expected 0.14, missing expectations. The chart below visualizes how AZTA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AZTA has released its 2026 Q1 earnings report, with revenue of 148.64M, reflecting a YoY change of 0.82%, and net profit of -15.43M, showing a YoY change of -40.39%. The Sankey diagram below clearly presents AZTA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
